NEW MJ NEWS

AbbVie to Present at the Piper Sandler Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference on Wednesday, December 1, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present at 9:30 a.m. CT.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-piper-sandler-healthcare-conference-301430238.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$PHOT The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf…

Cronos Group Inc. (CRON) (CRON.TO) Appoints Dr. Todd Abraham as Chief Innovation Officer

Cronos Group Appoints Dr. Todd Abraham as Chief Innovation Officer   Cronos…

GrowGeneration Corp. (GRWG) Acquires Mendocino Greenhouse and Garden Supply

GrowGeneration Acquires Mendocino Greenhouse and Garden Supply, Expands Footprint in California’s Emerald…

$INSY Initiates Five Phase III Clinical Trials

Insys Therapeutics to Initiate Five Phase III Clinical Trials in 2015 PHOENIX,…